Neuroprotective Mechanisms of the ACE2-Angiotensin-(1-7)-Mas Axis in Stroke

被引:73
|
作者
Bennion, Douglas M. [1 ,2 ]
Haltigan, Emily [1 ,2 ]
Regenhardt, Robert W. [1 ,2 ]
Steckelings, U. Muscha [3 ]
Sumners, Colin [1 ,2 ]
机构
[1] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA
[2] Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA
[3] Univ Southern Denmark, Dept Cardiovasc & Renal Res, DK-5000 Odense C, Denmark
关键词
Angiotensin converting enzyme 2; Angiotensin-(1-7); Mas; Angiotensin type 1 receptor; Angiotensin type 2 receptor; Renin-angiotensin system; Stroke; Neuroprotection; Neuron; Microglia; Ischemia; Intracerebral hemorrhage; Inflammation; CONVERTING ENZYME 2; II TYPE-2 RECEPTOR; NITRIC-OXIDE SYNTHASE; SPONTANEOUSLY HYPERTENSIVE-RATS; IMPROVES ENDOTHELIAL FUNCTION; CEREBRAL-ARTERY OCCLUSION; RENIN-ANGIOTENSIN-SYSTEM; ISCHEMIC-STROKE; AT2; RECEPTOR; KAPPA-B;
D O I
10.1007/s11906-014-0512-2
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The discovery of beneficial neuroprotective effects of the angiotensin converting enzyme 2-angiotensin-(1-7)Mas axis [ACE2-Ang-(1-7)-Mas] in ischemic and hemorrhagic stroke has spurred interest in a more complete characterization of its mechanisms of action. Here, we summarize findings that describe the protective role of the ACE2Ang-(1-7)-Mas axis in stroke, along with a focused discussion on the potential mechanisms of neuroprotective effects of Ang-(1-7) in stroke. The latter incorporates evidence describing the actions of Ang-(1-7) to counter the deleterious effects of angiotensin II (AngII) via its type 1 receptor, including antiinflammatory, anti-oxidant, vasodilatory, and angiogenic effects, and the role of altered kinase-phosphatase signaling. Interactions of Mas with other receptors, including bradykinin receptors and AngII type 2 receptors are also considered. A more complete understanding of the mechanisms of action of Ang-(1-7) to elicit neuroprotection will serve as an essential step toward research into potential targeted therapeutics in the clinical setting.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
    Santos, Robson A. S.
    Ferreira, Anderson J.
    Simoes E Silva, Ana Cristina
    EXPERIMENTAL PHYSIOLOGY, 2008, 93 (05) : 519 - 527
  • [32] The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function
    Ferrario, Carlos M.
    Varagic, Jasmina
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2010, 298 (06) : F1297 - F1305
  • [33] ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good
    Xu, Ping
    Sriramula, Srinivas
    Lazartigues, Eric
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2011, 300 (04) : R804 - R817
  • [34] Role of the ACE2/Ang-(1-7)/Mas axis in glucose metabolism
    Zhao, Shiyuan
    Sun, Wenxue
    Jiang, Pei
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2021, 22 (03) : 769 - 777
  • [35] HARMONIC COMPLEXITY WITHIN THE RENIN ANGIOTENSIN SYSTEM: ROLE OF THE ANG-(1-7)/ACE2/MAS RECEPTOR AXIS
    Ferrario, C. M.
    HYPERTENSION, 2009, 53 (06) : 1106 - 1106
  • [36] Harmonic complexity within the renin angiotensin system: Role of the Ang-(1-7)/ACE2/mas receptor axis
    Ferrario, Carlos M.
    ENDOCRINE JOURNAL, 2010, 57 : S267 - S267
  • [37] Role of the ACE2/angiotensin1-7/Mas axis in the cardiovascular system
    Iwai, Masaru
    Horiuchi, Masatsugu
    HYPERTENSION RESEARCH, 2010, 33 (11) : 1108 - 1109
  • [38] Role of the ACE2/angiotensin1–7/Mas axis in the cardiovascular system
    Masaru Iwai
    Masatsugu Horiuchi
    Hypertension Research, 2010, 33 : 1108 - 1109
  • [39] ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis
    Simoes e Silva, Ana Cristina
    Teixeira, Mauro Martins
    PHARMACOLOGICAL RESEARCH, 2016, 107 : 154 - 162
  • [40] Evidence that the ACE2-angiotensin-(1-7) pathway counterbalances angiotensin II-induced formation of reactive oxygen species in renal nuclei
    Gwathmey, Tanya M.
    Pendergrass, Karl D.
    Reid, Sean D.
    Rose, James C.
    Chappell, Mark C.
    HYPERTENSION, 2008, 52 (04) : E124 - E125